TNF Blocking Therapies and Immunomonitoring in Patients With Inflammatory Bowel Disease

Mediators of Inflammation - Egypt
doi 10.1155/2014/172821
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Recommended Drug Therapies for Inflammatory Bowel Disease

Prescriber
Pharmacology
2018English

The Effect of Anti-TNF Therapy on Thyroid Function in Patients With Inflammatory Bowel Disease

Endocrine Journal
EndocrinologyMetabolismDiabetes
2018English

Pain Management in Patients With Inflammatory Bowel Disease

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2014English

Ophthalmologic Manifestations in Patients With Inflammatory Bowel Disease

Intestinal Research
Gastroenterology
2017English

Psychiatric Illness in Patients With Inflammatory Bowel Disease.

Gut
Gastroenterology
1987English

MYO9B Polymorphisms in Patients With Inflammatory Bowel Disease

Gut
Gastroenterology
2007English

Anti-Adhesion Therapies in Inflammatory Bowel Disease—Molecular and Clinical Aspects

Frontiers in Immunology
AllergyImmunology
2017English

Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?

PLoS ONE
Multidisciplinary
2016English

Review Article: Novel Oral-Targeted Therapies in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy